# Theradaptive

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/theradaptive

- Industry: Biotechnology
- Headquarters: Frederick, US
- Website: www.theradaptive.com
- Total disclosed funding: $6.2M
- Latest round: Seed (Nov 9, 2021)
- Investors on record: 2

## About

Founded in 2017 by Luis M. Alvarez, and based in Maryland, US, Theradaptive, Inc. operates as a biopharmaceutical and medical device company that provides a therapeutic delivery platform for multiple clinical indications and develops new regenerative therapies. In June 2023, Theradaptive, Inc. raised USD 26 million in Series A funding from investors. The firm operates from Frederick (HQ) and Maryland with other locations in Boston, Orlando, and Memphis.



The company creates and sells a proprietary protein-engineering technology platform that converts proteins into material-binding variants that are then used to coat implants, devices, and injectable carriers. The technology allows the company to develop therapies and deliver therapeutics to any part of the body, which aids in the treatment of immuno-oncology, spine, orthopedics, and soft tissue repair.



The company intends to use the June 2023 funding to scale up manufacturing practices in preparation for first-in-human clinical trials later this year, expand the platform beyond orthopedics to additional indications such as oncology and dental, and advance the development of its targeted regenerative therapeutics.

## Funding rounds

- Seed, Nov 9, 2021, $6.2M — Maryland Venture Fund, Orthorebirth Co. Ltd

## Investors

- Maryland Venture Fund (https://capitalatlas.ai/funds/maryland-venture-fund) — Seed
- Orthorebirth Co. Ltd — Seed